CEO Bent Frandsen and CFO Keith Alexander will present ExpreS2ion’s 2026 Interim Report (Q3) at a virtual investor event hosted by H.C. Andersen Capital.

The presentation will include an update on the Company’s clinical progress, partnered programmes, platform activities and financial position. Investors may register for the webcast and submit questions in advance via the Inderes platform.

The event is free and open to all investors.